We are live on ! Find out more
REVBW icon

Revelation Biosciences Warrant

15 hedge funds and large institutions have $3.71M invested in Revelation Biosciences Warrant in 2021 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

700% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 1

88% more funds holding

Funds holding: 815 (+7)

33% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 3

51% less capital invested

Capital invested by funds: $7.54M → $3.71M (-$3.82M)

Holders
15
Holders Change
+7
Holders Change %
+87.5%
% of All Funds
0.26%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
8
Increased
2
Reduced
3
Closed
1
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
BFM
1
Boothbay Fund Management
New York
$2.35M -$277K -296,784 -56%
PAMP
2
Polar Asset Management Partners
Ontario, Canada
$364K +$327K +350,000 +100%
LA
3
Linden Advisors
New York
$343K -$18.9K -20,174 -3%
CH
4
CVI Holdings
Delaware
$156K +$280K +300,000 New
YCM
5
Yakira Capital Management
Connecticut
$139K
ICM
6
Ionic Capital Management
New York
$130K
RCM
7
Rivernorth Capital Management
Florida
$104K +$3.16K +3,382 +2%
MP
8
Mangrove Partners
Connecticut
$49K +$88.9K +95,100 New
Jane Street
9
Jane Street
New York
$28K +$51.1K +54,677 New
Walleye Trading
10
Walleye Trading
New York
$24K +$43.9K +47,000 New
EAM
11
Exos Asset Management
New York
$10K +$17.8K +19,000 New
ES
12
Equitec Specialists
Illinois
$9K -$23.3K -24,950 -58%
PAM
13
Panagora Asset Management
Massachusetts
$4K +$7.41K +7,931 New
UBS Group
14
UBS Group
Switzerland
$1K +$1.23K +1,317 New
Walleye Capital
15
Walleye Capital
New York
$37 +$66.4K +71,000 New
Hudson Bay Capital Management
16
Hudson Bay Capital Management
Connecticut
-$612K -693,000 Closed

REVBW Hedge Fund Activity: Q1 2021 in Review

15 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Revelation Biosciences Warrant (REVBW) for Q1 2021, worth a combined $3.71M — down 51% from $7.54M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new REVBW positions and 1 closed out — a net gain of 7 holders — while 2 added to existing stakes and 3 trimmed.

The largest buyer was Polar Asset Management Partners, adding an estimated $327K. The largest seller was Hudson Bay Capital Management, exiting entirely with an estimated $612K sold.

  • 15 institutional investors held Revelation Biosciences Warrant (REVBW) as of Q1 2021, up from 8 in Q4 2020.
  • Funds reported $3.71M of Revelation Biosciences Warrant stock for Q1 2021, down 51% quarter-over-quarter.
  • 8 funds opened new Revelation Biosciences Warrant positions in Q1 2021 and 1 closed out, a net change of +7 holders.
  • The largest Revelation Biosciences Warrant buyer in Q1 2021 was Polar Asset Management Partners, an estimated $327K added.
  • The largest Revelation Biosciences Warrant seller in Q1 2021 was Hudson Bay Capital Management, an estimated $612K sold.

Based on aggregated 13F filings for Q1 2021.